top of page

Food and Drug Administration (FDA) Regulation of Cannabis and Cannabis-Derived Products, Including Cannabidiol (CBD) 

Title
Article
Release Date
Webpage
Public Health Focus
FDA Regulation of Cannabis and Cannabis-Derived Products, Including Cannabidiol (CBD)
01/22/2021
https://www.fda.gov/news-events/public-health-focus/fda-regulation-cannabis-and-cannabis-derived-products-including-cannabidiol-cbd
FDA NEWS RELEASE
Better Data for a Better Understanding of the Use and Safety Profile of Cannabidiol (CBD) Products
01/08/2021
https://www.fda.gov/news-events/fda-voices/better-data-better-understanding-use-and-safety-profile-cannabidiol-cbd-products
FDA NEWS RELEASE
FDA Warns Companies Illegally Selling CBD Products
12/22/2020
https://www.fda.gov/news-events/press-announcements/fda-warns-companies-illegally-selling-cbd-products
FDA NEWS RELEASE
FDA, FTC warn company marketing unapproved cannabidiol products with unsubstantiated claims to treat teething and ear pain in infants, autism, ADHD, Parkinson’s and Alzheimer’s disease
10/22/2019
https://www.fda.gov/news-events/press-announcements/fda-ftc-warn-company-marketing-unapproved-cannabidiol-products-unsubstantiated-claims-treat-teething
Public Health Focus
FDA and Cannabis: Research and Drug Approval Process
10/01/2020
https://www.fda.gov/news-events/public-health-focus/fda-and-cannabis-research-and-drug-approval-process
FDA NEWS RELEASE
FDA Approves New Indication for Drug Containing an Active Ingredient Derived from Cannabis to Treat Seizures in Rare Genetic Disease
07/31/2020
https://www.fda.gov/news-events/press-announcements/fda-approves-new-indication-drug-containing-active-ingredient-derived-cannabis-treat-seizures-rare
FDA NEWS RELEASE
FDA In Brief: FDA Issues Draft Guidance to Encourage Cannabis-Related Clinical Research
07/21/2020
https://www.fda.gov/news-events/fda-brief/fda-brief-fda-issues-draft-guidance-encourage-cannabis-related-clinical-research
FDA NEWS RELEASE
FDA Approves First Drug Comprised of an Active Ingredient Derived from Marijuana to Treat Rare, Severe Forms of Epilepsy
03/27/2020
https://www.fda.gov/news-events/press-announcements/fda-approves-first-drug-comprised-active-ingredient-derived-marijuana-treat-rare-severe-forms
FDA NEWS RELEASE
FDA Advances Work Related to Cannabidiol Products with Focus on Protecting Public Health, Providing Market Clarity
03/05/2020
https://www.fda.gov/news-events/press-announcements/fda-advances-work-related-cannabidiol-products-focus-protecting-public-health-providing-market
FDA NEWS RELEASE
Cannabis Policies For the New Decade
01/15/2020
https://www.fda.gov/news-events/congressional-testimony/cannabis-policies-new-decade-01152020
FDA NEWS RELEASE
FDA warns 15 companies for illegally selling various products containing cannabidiol as agency details safety concerns
11/25/2019
https://www.fda.gov/news-events/press-announcements/fda-warns-15-companies-illegally-selling-various-products-containing-cannabidiol-agency-details
bottom of page